 |
| |
| Nov-11-19 | Resumed |
Cantor Fitzgerald |
Overweight |
$50 → $13 |
|
| Jul-08-19 | Initiated |
H.C. Wainwright |
Buy |
$8 |
|
| Mar-21-19 | Initiated |
Evercore ISI |
Outperform |
$26 |
|
| Jan-28-19 | Initiated |
Northland Capital |
Outperform |
$50 |
|
| Jan-28-19 | Initiated |
National Securities |
Sell |
$5 |
|
| Dec-20-18 | Initiated |
Piper Jaffray |
Overweight |
|
|
|
|
| Apr-08-20 08:00AM | PolarityTE Announces Conclusion of SEC Investigation Business Wire +11.17% |
| Apr-06-20 08:00AM | PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of Directors Business Wire +5.54% |
| Apr-01-20 08:00AM | PolarityTE Announces Appointment of David Seaburg as CEO and Restructuring of Executive Team Business Wire -12.75% |
| Mar-15-20 09:26AM | Earnings Release: Here's Why Analysts Cut Their PolarityTE, Inc. Price Target To US$10.17 Simply Wall St. |
| Mar-12-20 07:00AM | PolarityTE Reports Fiscal Year 2019 Financial Results Business Wire -7.48% |
| Mar-05-20 08:00AM | PolarityTE to Attend the Oppenheimer 30th Annual Healthcare Conference Business Wire |
| Mar-03-20 08:00AM | PolarityTE to Report Fiscal Year 2019 Financial Results on March 12, 2020 Business Wire |
| Feb-18-20 06:38PM | Bragar Eagel & Squire is Investigating Certain Officers and Directors of PolarityTE, comScore, AMC, and Conagra Brands and Encourages Investors to Contact the Firm GlobeNewswire -5.92% |
| Feb-12-20 09:24AM | PolarityTE's stock loses nearly half its value after public offering of stocks, warrants MarketWatch -47.17% |
| 09:00AM | PolarityTE Announces Pricing of Public Offering of Common Stock and Warrants Business Wire |
| Feb-11-20 04:01PM | PolarityTE Announces Public Offering of Common Stock and Warrants Business Wire |
| Dec-19-19 06:29PM | Hedge Funds Are Crazy About PolarityTE, Inc. (PTE) Insider Monkey |
| Dec-18-19 08:00AM | PolarityTE to Participate in Corporate Access Event in San Francisco, January 13-15, 2020 Business Wire |
| Dec-12-19 09:11AM | Is the Options Market Predicting a Spike in PolarityTE (PTE) Stock? Zacks |
| Dec-10-19 08:00AM | PolarityTE Builds Patent Portfolio with New International Patent Grants Business Wire |
| Dec-06-19 08:00AM | 12 Biotech Stocks Primed For A Short Squeeze Benzinga +9.27% |
| Dec-05-19 08:00AM | PolarityTE Announces Equity Purchase Agreement for up to $25 Million with Keystone Capital Partners Business Wire -12.79% |
| Nov-28-19 09:42AM | Here's Why We're A Bit Worried About PolarityTE's (NASDAQ:PTE) Cash Burn Situation Simply Wall St. |
| Nov-27-19 08:00AM | PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference TEST Business Wire Releases |
| 08:00AM | PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference Business Wire |
| Nov-19-19 04:55PM | SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PolarityTE, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire |
| Nov-12-19 04:05PM | PolarityTE Reports Third Calendar Quarter 2019 Results Business Wire -11.55% |
| Nov-07-19 04:01PM | PolarityTE Adopts Short-Term Shareholder Rights Plan Business Wire |
| Oct-24-19 08:00AM | PolarityTE to Report Calendar Third Quarter Financial Results on November 12, 2019 Business Wire -7.93% |
| Oct-14-19 03:36PM | PolarityTE, Inc. (NASDAQ:PTE): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St. |
| 08:00AM | PolarityTE Announces Positive Pilot Study Data of SkinTE as a Treatment for Venous Stasis Leg Ulcers Business Wire |
| Oct-06-19 10:00AM | Bragar Eagel & Squire is Investigating Certain Officers and Directors of National General Holdings, Natural Health Trends, Omnicell, and Polarity TE and Encourages Investors to Contact the Firm GlobeNewswire |
| Oct-03-19 08:00AM | SkinTE Data to be Presented at the 19th Annual Diabetic Foot Global Conference Business Wire |
| Sep-26-19 08:00AM | PolarityTE Selected to Present at 2019 Cell & Gene Meeting on the Mesa Business Wire -8.98% |
| Sep-23-19 08:00AM | PolarityTE Announces Positive Data Showing SkinTE Regenerated Full-Thickness Skin in Difficult-to-Treat Wounds Business Wire +5.78% |
| Sep-18-19 08:00AM | PolarityTE to Attend the 2019 Cantor Global Healthcare Conference Business Wire |
| Sep-16-19 08:00AM | SkinTE Data Including Final Pilot Study Data Readout to be Presented at the Symposium on Advanced Wound Care Fall Meeting Business Wire |
| Sep-09-19 08:00AM | SkinTE Data to be Presented at the American Society of Plastic Surgeons 88th Annual Scientific Meeting PR Newswire +5.44% |
| Sep-04-19 08:00AM | PolarityTE Appoints Peter Cohen as Chairman of the Board PR Newswire +8.89% |
| Aug-28-19 08:00AM | PolarityTE to Attend H.C. Wainwright 21st Annual Healthcare Conference and Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire +18.08% |
| Aug-20-19 01:43PM | Introducing PolarityTE (NASDAQ:PTE), The Stock That Tanked 80% Simply Wall St. |
| 12:55PM | PolarityTE Granted Canadian Patent PR Newswire |
| Aug-16-19 08:00AM | PolarityTE to Present at Military Health System Research Symposium on Platform Technology for Treatment of Traumatic and Chronic Wounds PR Newswire |
| Aug-08-19 07:00AM | PolarityTE Reports Second Calendar Quarter 2019 Results PR Newswire +19.44% |
| Jul-25-19 08:00AM | PolarityTE to Report Calendar Second Quarter Financial Results on August 8, 2019 PR Newswire |
| Jul-24-19 09:35AM | PolarityTE Enters Oversold Territory Zacks |
| Jun-29-19 07:17PM | Is PolarityTE, Inc. (PTE) A Good Stock To Buy ? Insider Monkey |
| Jun-19-19 12:30PM | What Type Of Shareholder Owns PolarityTE, Inc.'s (NASDAQ:PTE)? Simply Wall St. |
| Jun-12-19 11:49AM | Weekly CFO Buys Highlight GuruFocus.com |
| Jun-10-19 10:09AM | PolarityTE Shares Rally On Positive Readout From Skin Graft Study In Diabetic Foot Ulcers Benzinga |
| 08:00AM | PolarityTE Announces Final Clinical Data from Pilot Study Showing Closure of Diabetic Foot Ulcers Using SkinTE PR Newswire |
| Jun-08-19 05:38PM | Ready Trader One: Events, Stocks To Watch At E3 Benzinga |
| Jun-03-19 08:00AM | PolarityTE Creates Office of the Chief Executive to Focus on Commercialization and Operational Performance PR Newswire |
| May-31-19 01:33PM | Analysts Recommend These 3 Falling Knives GuruFocus.com |
| May-21-19 08:00AM | Final Data from Pilot Study on Use of SkinTE for Diabetic Foot Ulcers Accepted as Late-Breaking Abstract at the American Diabetes Association's 79th Scientific Sessions Conference PR Newswire |
| May-20-19 11:26AM | Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks -9.79% |
| May-10-19 09:55AM | 3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates Zacks |
| 07:30AM | PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE PR Newswire |
| 07:16AM | PolarityTE Reports First Calendar Quarter 2019 Results PR Newswire |
| May-02-19 09:00AM | Should You Be Concerned About PolarityTE, Inc.'s (NASDAQ:PTE) Historical Volatility? Simply Wall St. +6.72% |
| May-01-19 08:00AM | PolarityTE to Report Calendar First Quarter Financial Results on May 10, 2019 PR Newswire |
| Apr-24-19 08:00AM | SkinTE Clinical Data to be Presented, PolarityTE to Host Booth and SkinTE Event at Symposium on Advanced Wound Care (SAWC) Spring, Wound Healing Society Meeting PR Newswire |
| Apr-10-19 11:00AM | Why PolarityTE Is Sinking Today Motley Fool -10.18% |
| 09:30AM | PolarityTE Announces Pricing of Public Offering of Common Stock PR Newswire |
| Apr-09-19 04:01PM | PolarityTE Announces Public Offering of Common Stock PR Newswire |
| Apr-02-19 04:34PM | Lifshitz & Miller LLP Announces Investigation of Bloom Energy Corporation, First Choice Healthcare Solutions, Inc., Nutanix, Inc., PolarityTE, Inc., Revlon, Inc., Tivity Health, Inc., WellCare Health Plans, Inc., and Whitestone REIT PR Newswire |
| Apr-01-19 08:00AM | PolarityTE Enrolls First Patients in Two Clinical Trials Evaluating SkinTE for the Treatment of Chronic Wounds PR Newswire |
| Mar-29-19 08:00AM | PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer PR Newswire |
| Mar-27-19 08:00AM | Clinical Outcomes Data on SkinTE from Lower Extremity Chronic Wounds to be Presented at Diabetic Limb Salvage (DLS) Conference PR Newswire |
| Mar-21-19 08:00AM | PolarityTE Hosts Symposium Featuring SkinTE-Treated Burn Survivor, New Clinical Data at American Burn Association Annual Meeting PR Newswire +9.60% |
| Mar-19-19 05:00PM | PolarityTE to Present at Oppenheimer 29th Annual Healthcare Conference PR Newswire |
| 02:15PM | RM LAW Announces Investigation of PolarityTE, Inc. PR Newswire |
| 01:06PM | Federman & Sherwood Investigates PolarityTE, Inc. for Possible Violations of Federal Securities Laws Business Wire |
| 10:47AM | PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation of PolarityTE, Inc. - PTE GlobeNewswire |
| Mar-18-19 07:56PM | Bragar Eagel & Squire, P.C. is Investigating PolarityTE, Inc. (PTE) on Behalf of Stockholders and Encourages PTE Investors to Contact the Firm GlobeNewswire -15.64% |
| 05:40PM | PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation Of PolarityTE, Inc. - PTE PR Newswire |
| 04:20PM | Why PolarityTE Stock Tanked Today Motley Fool |
| 02:16PM | Biotech's shares tumble after it says SEC is looking into possible manipulation CNBC |
| 07:00AM | PolarityTE Reports Results and Corporate Update for Two-Month Transition Period Ended December 31, 2018 PR Newswire |
| Mar-14-19 10:20AM | Read This Before Buying PolarityTE, Inc. (NASDAQ:PTE) Shares Simply Wall St. |
| Mar-13-19 08:45AM | PolarityTE to Attend Medlab Asia Pacific and Asia Health 2019 Conferences PR Newswire |
| Mar-11-19 11:39AM | Why PolarityTE Stock Is Shooting Higher Today Motley Fool +22.25% |
| 10:30AM | Will Polarity (PTE) Report Negative Q1 Earnings? What You Should Know Zacks |
| Mar-06-19 04:01PM | PolarityTE to Present at the 39th Annual Cowen Healthcare Conference and at the 13th Annual Canaccord Genuity Musculoskeletal Conference PR Newswire |
| Mar-05-19 08:00AM | Congressional Health Care Innovation Showcase to Feature PolarityTE PR Newswire |
| Feb-27-19 08:00AM | PolarityTE Presents Platform Technology at Department of Defense Pacific Operational Science and Technology (POST) Conference PR Newswire |
| Feb-25-19 10:10AM | Zacks.com featured expert Kevin Matras highlights: Shenandoah Telecommunications, Honda Motor, PolarityTE, Ubiquiti Networks and Titan Machinery Zacks |
| Feb-22-19 09:06AM | 5 Stocks to Buy as New Analysts Initiate Coverage Zacks |
| Feb-06-19 07:12AM | PolarityTE, Inc. (NASDAQ:PTE): The Best Of Both Worlds Simply Wall St. |
| Feb-01-19 11:30AM | LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE |
| 08:00AM | Boswick Burn and Wound Symposium: New Data to be Presented on Preclinical and Clinical Use of SkinTE PR Newswire |
| Jan-29-19 04:15PM | PolarityTE Names Board Member David Seaburg as President of Corporate Development PR Newswire |
| Jan-23-19 08:50AM | Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks |
| 08:00AM | World Stem Cell Summit: PolarityTE to Present Abstract on Regenerative Platform Technology PR Newswire |
| Jan-14-19 07:00AM | PolarityTE Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire |
| Jan-07-19 08:00AM | PolarityTE Expands Contract Services Business with Addition of Jon Burrows PR Newswire -6.13% |
| Jan-03-19 08:00AM | PolarityTE to Report Fiscal Fourth Quarter Financial Results on January 14, 2019 PR Newswire |
| Dec-28-18 08:00AM | PolarityTE Registers OsteoTE with U.S. Food and Drug Administration PR Newswire |
| Dec-27-18 08:00AM | PolarityTE to Participate in Corporate Access Event in San Francisco, January 7-9, 2019 PR Newswire |
| Dec-24-18 10:21AM | Investors Are Undervaluing PolarityTE, Inc. (NASDAQ:PTE) By 32.74% Simply Wall St. |
| Dec-19-18 08:00AM | PolarityTE and University Hospitals Cleveland Medical Center Announce System-Wide Approval of SkinTE PR Newswire +8.85% |
| Dec-11-18 08:00AM | PolarityTE Announces Former FDA Official and Johnson & Johnson Executive Minnie Baylor-Henry Joins Board of Directors PR Newswire +17.64% |
| Dec-04-18 08:00AM | PolarityTE to Present SkinTE Clinical Outcomes at Innovations in Wound Healing Conference PR Newswire -7.19% |
| Nov-29-18 08:00AM | PolarityTE Announces Recognition of SkinTE as Finalist for Fierce Innovation Awards Biotech Innovation PR Newswire |
| Nov-27-18 07:00AM | PolarityTE Announces Matt Kemp as Chief Commercial Officer PR Newswire |
|
|
|
|
| PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Lough Denver | Prior Director and Officer | Apr 02 | Option Exercise | 0.00 | 11,111 | 0 | 7,123,878 | Apr 03 11:45 AM | | Mann Paul Elliot | Chief Financial Officer | Mar 31 | Sale | 1.04 | 23,158 | 24,084 | 415,953 | Apr 02 04:30 PM | | Seaburg David B | Chief Executive Officer | Mar 31 | Sale | 1.04 | 21,287 | 22,138 | 345,965 | Apr 02 04:30 PM | | Hoyler Cameron J. | Gen. Counsel & Exec. VP | Mar 30 | Sale | 1.15 | 936 | 1,076 | 323,120 | Mar 31 08:16 PM | | Mann Paul Elliot | Chief Financial Officer | Mar 23 | Sale | 1.05 | 1,283 | 1,347 | 439,111 | Mar 25 09:05 PM | | Hoyler Cameron J. | Gen. Counsel & Exec. VP | Mar 23 | Sale | 1.05 | 3,500 | 3,675 | 324,056 | Mar 25 09:03 PM | | Lough Denver | Prior Director and Officer | Mar 03 | Option Exercise | 0.00 | 11,111 | 0 | 7,116,001 | Mar 04 07:08 PM | | Seaburg David B | President | Mar 03 | Sale | 1.34 | 5,450 | 7,303 | 367,251 | Mar 04 04:30 PM | | Hague Richard | Chief Operating Officer | Feb 07 | Sale | 3.02 | 12,950 | 39,109 | 321,895 | Feb 07 09:32 PM | | Mann Paul Elliot | Chief Financial Officer | Feb 07 | Sale | 3.02 | 12,833 | 38,756 | 440,393 | Feb 07 09:30 PM | | Hoyler Cameron J. | Gen. Counsel & Exec. VP | Feb 07 | Sale | 3.04 | 11,667 | 35,468 | 327,556 | Feb 07 09:28 PM | | Seaburg David B | President | Feb 07 | Sale | 3.02 | 16,333 | 49,326 | 372,701 | Feb 07 09:26 PM | | Lough Denver | Prior Director and Officer | Feb 04 | Option Exercise | 0.00 | 11,111 | 0 | 7,108,602 | Feb 05 10:22 AM | | Lough Denver | Prior Director and Officer | Jan 16 | Option Exercise | 3.12 | 10,000 | 31,200 | 10,000 | Jan 21 06:59 PM | | Lough Denver | Prior Director and Officer | Jan 16 | Sale | 4.17 | 10,000 | 41,700 | 0 | Jan 21 06:59 PM | | Lough Denver | Prior Director and Officer | Jan 03 | Option Exercise | 0.00 | 11,111 | 0 | 7,097,491 | Jan 06 03:01 PM | | Mann Paul Elliot | Chief Financial Officer | Dec 23 | Sale | 2.71 | 11,000 | 29,810 | 453,227 | Dec 23 08:12 PM | | Erdtmann Rainer M | Director | Dec 16 | Sale | 2.47 | 31,846 | 78,660 | 30,000 | Dec 17 04:30 PM | | Hoyler Cameron J. | Gen. Counsel & Exec. VP | Nov 19 | Sale | 3.15 | 7,100 | 22,365 | 339,223 | Nov 22 09:32 AM |
|
|
|
|
|
|
